Sympatient
PrivateLast Round
Series A
Sep 29, 2022
Total Funding Raised
$9.07M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sympatient is a health technology company that develops PsyOS®, a software-enabled care infrastructure designed to make psychotherapy more accessible, scalable, and efficient within regulated healthcare systems.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Medical Devices, AR/VR Experiences, Patient Engagement
Business Model
B2B2C
Customer Profile
Government Contracts, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sympatient Comparables
Compare Sympatient with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HelloBetter | 87% | |
| Mindable Health | 86% | |
| MEDICE Arzneimittel Pütter | 85% |
Sympatient Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 29, 2022 | ||||
| Seed | May 28, 2020 |
Sympatient Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed, Series A |
| IFB Hamburg | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 124% MoM, reaching 4.9K.
- Jun 1, 2025
Monthly visitors increased 77% MoM, reaching 9.4K.
Sympatient Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sympatient's valuation, stock price, and market status.
Is Sympatient a public or private company?
Sympatient is a private company.
What is the current stock price of Sympatient?
Sympatient is a private company with no public stock price. No recent secondary market data is available.
How much is Sympatient worth (valuation)?
Valuation information for Sympatient is not publicly available.
Can I buy Sympatient stock?
Sympatient shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sympatient's last funding round?
Sympatient's most recent funding round was Series A on September 29, 2022.
Who are the main investors in Sympatient?
Key investors in Sympatient include Verve Ventures.
Will Sympatient IPO soon?
No public IPO plans have been announced for Sympatient.
How can I track Sympatient secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sympatient's secondary market activity and sign up for updates.